Paper Details
- Home
- Paper Details
Prevention of exercise-induced asthma by a fixed combination of disodium cromoglycate plus reproterol compared with montelukast in young patients.
Author: KremerHans-Joachim, LechelerJosef, MausJoachim, MunzelUllrich, NguyenDuc Tung, PetzoldUrsula, PfannebeckerBernhard
Original Abstract of the Article :
BACKGROUND: The leukotriene inhibitor montelukast has been recommended against exercise-induced asthma (EIA), however, single-dose agents might be favourable in several aspects. OBJECTIVE: To compare the protective effects against EIA of a single inhalation of the combination disodium cromoglycate ...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1055/s-0031-1296511
データ提供:米国国立医学図書館(NLM)
Preventing Exercise-Induced Asthma: Comparing Disodium Cromoglycate/Reproterol and Montelukast
This research compares the effectiveness of a fixed combination of disodium cromoglycate (DSCG) and reproterol (REP) with montelukast in preventing exercise-induced asthma (EIA). The study uses a cross-over design, randomly assigning patients to receive either a single inhalation of DSCG/REP or three days of oral montelukast before an exercise challenge. The researchers found that DSCG/REP provided significantly better protection against EIA than montelukast. This study offers valuable insights into the optimal strategies for preventing EIA, highlighting the potential advantages of a fixed combination of medications.
Optimizing Asthma Management: A Multifaceted Approach
This study underscores the importance of finding effective and personalized strategies for managing asthma. The researchers' findings suggest that different medications may have varying levels of effectiveness in preventing EIA. This highlights the need for ongoing research and for tailoring treatment plans to meet individual patient needs. This research provides a framework for developing more effective and individualized asthma management plans, ultimately improving patient outcomes and quality of life.
Living with Asthma: Finding the Right Path
This research offers hope for individuals with asthma who experience EIA. The study's findings suggest that a fixed combination of DSCG/REP may offer better protection than other medications, potentially reducing the frequency and severity of EIA episodes. This research underscores the importance of working closely with a healthcare professional to identify the most effective treatment strategies for asthma. Just as a camel navigates a winding desert path, individuals with asthma can find the right path to managing their condition with the guidance of a knowledgeable healthcare team.
Dr.Camel's Conclusion
This study highlights the importance of finding the right treatment strategies for asthma. Just as a camel navigates a vast and challenging desert, individuals with asthma can find their way to better health and well-being with the right guidance and support. This research offers a beacon of hope for individuals struggling with EIA, suggesting that a combination of DSCG/REP may offer a more effective solution than other medications.
Date :
- Date Completed 2008-08-29
- Date Revised 2021-12-03
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.